KGbio
Atiya A. is a legal professional with extensive experience in various aspects of law, including intellectual property, corporate security, compliance, and more. Atiya has worked in a diverse range of companies and roles, from legal intern at the Directorate General of Immigration to Chief Executive Officer at PT PMD - Knowlex.ID and Legal Compliance Manager at KGbio. Atiya A. is skilled in providing legal advice, managing projects, conducting research, drafting agreements, and ensuring legal compliance across multiple organizations and industries.
This person is not in any teams
KGbio
KGbio is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside the US/Canada, Western Europe and China. The business model revolves around in-licensing novel biologics and select biosimilars in oncology and high-specialty therapeutic areas (typically pre-IND or early clinical stage), with the objective to out-license them in target geographies after finishing clinical development as well as regulatory and reimbursement approvals. Platforms of interest currently include Fc-fusion proteins, antibodies, bispecifics, ADCs, cell therapies and therapeutic vaccines. The company is backed by Asian pharma companies Kalbe (market cap US$5.5 billion) and Genexine (market cap US$1.3 billion) and US private equity giant General Atlantic (AUM US$ 78 billion).